Cargando…

Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives

Risk stratification in pulmonary arterial hypertension (PAH) is crucial in assessing patient prognosis. It serves a prominent role in everyday patient care and can be determined using several validated risk assessment scores worldwide. The recently published 2022 European Society of Cardiology (ESC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vraka, Argyro, Diamanti, Eleni, Kularatne, Mithum, Yerly, Patrick, Lador, Frédéric, Aubert, John-David, Lechartier, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342910/ https://www.ncbi.nlm.nih.gov/pubmed/37445381 http://dx.doi.org/10.3390/jcm12134349

Ejemplares similares

Carbon Monoxide Diffusion Capacity as a Severity Marker in Pulmonary Hypertension
por: Diamanti, Eleni, et al.
Publicado: (2021)

The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model
por: Genecand, Léon, et al.
Publicado: (2023)

Pressure Overload and Right Ventricular Failure: From Pathophysiology to Treatment
por: Dayer, Nicolas, et al.
Publicado: (2023)

Editorial: Pediatric Pulmonary Hypertension
por: Beghetti, Maurice, et al.
Publicado: (2015)

Association Between the Pulmonary Artery Pulsatility Index and Prognosis in Pulmonary Arterial Hypertension: A Multicentre Study
por: Ostad, Sam, et al.
Publicado: (2023)

Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective
por: Humbert, Marc, et al.
Publicado: (2021)

Novel biomarkers for risk stratification in pulmonary arterial hypertension
por: Zelniker, Thomas, et al.
Publicado: (2015)

Risk stratification and medical therapy of pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2019)

Pulmonary arterial hypertension: an update
por: Hoendermis, E. S.
Publicado: (2011)

Pulmonary hypertension in the elderly: a different disease?
por: Berra, Grégory, et al.
Publicado: (2016)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Pulmonary Hypertension and Indicators of Right Ventricular Function
por: von Siebenthal, Célia, et al.
Publicado: (2016)

The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension
por: Haddad, Francois, et al.
Publicado: (2022)

Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography
por: Mercurio, Valentina, et al.
Publicado: (2022)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

Updated Perspectives on Pulmonary Hypertension in COPD
por: Blanco, Isabel, et al.
Publicado: (2020)

Pulmonary Arterial Remodeling Is Related to the Risk Stratification and Right Ventricular-Pulmonary Arterial Coupling in Patients With Pulmonary Arterial Hypertension
por: Grignola, Juan C., et al.
Publicado: (2021)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
por: Kopp, Garance, et al.
Publicado: (2020)

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
por: Montani, David, et al.
Publicado: (2022)

Selexipag in the management of pulmonary arterial hypertension: an update
por: Coghlan, J Gerry, et al.
Publicado: (2019)

Correlation between Pulmonary Artery Pressure and Vortex Duration Determined by 4D Flow MRI in Main Pulmonary Artery in Patients with Suspicion of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
por: Deux, Jean-François, et al.
Publicado: (2022)

Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
por: Perros, Frédéric, et al.
Publicado: (2021)

The Growing Role of Echocardiography in Pulmonary Arterial Hypertension Risk Stratification: The Missing Piece
por: Miotti, Cristiano, et al.
Publicado: (2021)

Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review
por: Lokhorst, Chantal, et al.
Publicado: (2022)

Future perspectives in pulmonary arterial hypertension
por: Simonneau, Gérald, et al.
Publicado: (2016)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Updated perspective of EPAS1 and the role in pulmonary hypertension
por: Wang, Na, et al.
Publicado: (2023)

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
por: Koudstaal, Thomas, et al.
Publicado: (2020)

Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
por: Lewis, Robert A., et al.
Publicado: (2020)

Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
por: Alandejani, Faisal, et al.
Publicado: (2022)

Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management
por: Ltaief, Zied, et al.
Publicado: (2023)

Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)
por: Tamura, Yuichi, et al.
Publicado: (2021)

Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models
por: Fadah, Kahtan, et al.
Publicado: (2023)

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
por: Ramani, Gautam V, et al.
Publicado: (2010)

Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update
por: Wong, Alexandra K, et al.
Publicado: (2019)

Long-term outcome of patients with combined post- and pre-capillary pulmonary hypertension
por: Titz, Anna, et al.
Publicado: (2023)

Non-Invasive Cardiac Output Determination Using Magnetic Resonance Imaging and Thermodilution in Pulmonary Hypertension
por: Crowe, Lindsey A., et al.
Publicado: (2022)

Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective
por: Hansen, Lillian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8jnob7gb9h0ss7sh2v6rdujcoo